Top Markets
Coin of the day
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rang in aandelen #18092
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Aandeelprijs
$10.22
Laatst gesynchroniseerd: 2026-07-31
Marktkapitalisatie
$212.97M
Verandering (1 dag)
4.58%
Verandering (1 jaar)
78.08%
Land
CA
Handel Satellos Bioscience Inc. (MSCL)

Categorie

Koersgeschiedenis voor Satellos Bioscience Inc. (MSCL)
Hoogste slotkoers: $9.26 op 2026-07-01

Laagste slotkoers: $152.54 op 2008-01-01
Koersgeschiedenis van Satellos Bioscience Inc. van 2008 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 29.26%
2025 -20.28%
2024 84.25%
2023 91.27%
2022 -80.10%
2021 2.79%
2020 -11.41%
2019 10.94%
2018 37.66%
2017 -27.41%
2016 41.02%
2015 -8.55%
2014 -90.26%
2013 -52.35%
2012 195.82%
2011 -36.68%
2010 -30.40%
2009 333.63%
2008 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.33 -8.75%
AU
$757.71 6.76%
CH